Related Evidence · External / Pending Review
Red Cell Transfusion Compatibility in Sickle Cell Disease
Even with Rh and Kell matching and RH genotyping, patients who receive regular transfusions can encounter donor red cell antigens they lack.
BHOC Therapeutics · Evidence brief · Published · Updated
What the 2026 study found
- Transfused red cell units genotyped
- 700
- Patients on chronic transfusion
- 28
- Red cell antigens assessed
- 35
The median age at enrollment was nine years.
-
1.59
Donor antigens absent in the recipient per transfusion episode, for units from donors who identified as Black or Hispanic. An earlier cohort using the general donor inventory reported 3.5 per episode.
-
22%
114 of 514 units from Black donors to Black recipients introduced none of the 35 tested antigens that the recipient lacked. The corresponding result for Hispanic donors and recipients was 15 of 38 units, based on three recipients.
-
1
Clinically significant anti-Jkb antibody developed during the study. Jkb, S and Doa were among the most frequent antigen mismatches.
The 1.59 and 3.5 figures compare antigen exposure in separate cohorts using different matching protocols. The small cohort and historical comparison limit what the study can say about changes in alloimmunization or hemolytic reactions. Genotyping provides unit-level information for matching individual patients.
Why is compatible blood hard to find in sickle cell disease?
Sickle cell disease (SCD) includes sickle cell anemia (SCA). In patients who need repeated transfusions, exposure to donor antigens can trigger alloimmunization, the formation of antibodies against those antigens. Those antibodies can make it harder to find compatible units for later transfusions. Mewha and colleagues reported their cohort as SCD.
Relevance to Precision Oxygen Therapeutics
This study describes donor red cell compatibility. A separate BHOC research question is whether tissue oxygen delivery can be supported while compatible red cells are being located. Evaluating that question requires product-specific studies with oxygen delivery and clinical outcomes.
Sources
Mewha J, Vege S, Friedman DF, Makrm S, Ochoa G, Westhoff CM, Chou ST. Red cell antigen exposures in patients with sickle cell disease receiving transfusion from Black and Hispanic donors. Blood Red Cells & Iron. 2026;2(2):100059.